BridgeBio Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-729.89	-732.94	-543.35	-653.25	-484.65	-586.45
Depreciation & Amortization	5.34	5.43	6.08	6.49	6.77	5.84
Stock-Based Compensation	140.38	133.02	95.8	108.71	91.56	99.51
Other Adjustments	179.97	199.63	-111.3	5.27	-61.25	-12.43
Change in Receivables	-89.96	-134.72	-2.97	15.33	15.17	-19.75
Changes in Inventories	-29.17	-25.31	-	-	-	-
Changes in Accounts Payable	1.87	26.61	1.51	2.78	-0.35	2.83
Changes in Accrued Expenses	25.71	108	29.9	1.46	-14.4	32.72
Changes in Unearned Revenue	-11.24	-11.43	21.88	-5.44	15.26	-
Changes in Other Operating Activities	18.37	-14.21	-18.28	-9.08	12.4	-20.2
Operating Cash Flow	-443.95	-445.91	-520.73	-527.72	-419.49	-497.93
Capital Expenditures	-1.17	-1.1	-0.93	-1.31	-4.82	-13.25
Purchases of Intangible Assets	-6.9	-8.5	-7.98	-	-1.5	-35
Purchases of Investments	-80.86	-28.2	-114.08	-137.26	-193.06	-643.28
Proceeds from Sale of Investments	23.3	13.3	183.91	193.11	532.52	477.04
Other Investing Activities	-	-	-0.14	-0.5	120	13.65
Investing Cash Flow	-65.63	-24.49	60.78	54.03	453.15	-200.83
Long-Term Debt Issued	770	575	950	-	-	1,204
Long-Term Debt Repaid	-26.61	-474.46	-473.42	-	-20.49	-124.12
Net Long-Term Debt Issued (Repaid)	743.39	100.54	476.58	-	-20.49	1,080
Issuance of Common Stock	56.45	34.15	322.9	459.22	8.08	20.46
Repurchase of Common Stock	-99.02	-62.5	-7.53	-6.88	-1.56	-204.75
Net Common Stock Issued (Repurchased)	-42.58	-28.35	315.37	452.34	6.52	-184.28
Other Financing Activities	-16.46	287.11	-43.5	-0.8	0.84	-158.95
Financing Cash Flow	848.86	359.29	748.46	451.54	-13.13	736.45
Net Cash Flow	270.85	-111.1	288.51	-22.15	20.52	37.69
Free Cash Flow	-445.12	-447.01	-521.66	-529.03	-424.32	-511.18
FCF Margin	-76.75%	-89.03%	-235.08%	-5686.62%	-546.46%	-733.23%
Free Cash Flow Per Share	-2.31	-2.33	-2.80	-3.25	-2.88	-3.54
Levered Free Cash Flow	31.55	-536.4	-19.02	-648.29	-486.81	525.09
Unlevered Free Cash Flow	-515.69	-435.73	-554.08	-612.45	-497.34	-568.68

SEC Filings: 10-K · 10-Q